Gemcitabine and Erlotinib in Pancreatic Cancer

Reviewer: Neha Vapiwala, MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 2 de noviembre del 2005

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

nab-Paclitaxel, Gemcitabine Up Survival in Pancreatic Cancer

Oct 18, 2013

Improved overall and progression-free survival, response rate with combo versus gemcitabine

Drug Ups Effect of Gemcitabine in Pancreatic Cancer

Feb 29, 2012

Nanoparticle albumin-bound-paclitaxel increases gemcitabine levels by preventing its breakdown

CT Scans Can ID Gemcitabine Response in Pancreatic Cancer

Mar 20, 2014

Gemcitabine incorporation into tumor DNA variable; correlates with transport properties